Juvenile systemic lupus erythematosus with unusual manifestation of lupus-associated panniculitis

Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
H HashemieS Meller

Abstract

Juvenile systemic lupus erythematosus (JSLE) is a rare multisystem autoimmune disease with broad heterogeneity of clinical manifestations. Diagnosing JSLE is often very challenging. This life-threatening, unpredictable, and relapsing disease, which may affect various organ systems, requires interdisciplinary, lifelong care. Here, we report the case of a 13-year-old patient with JSLE suffering from recurrent arthralgia, lupus panniculitis, and rashes that were successfully treated with hydroxychloroquine and prednisolone.

References

May 9, 2012·Pediatric Clinics of North America·Deborah M Levy, Sylvia Kamphuis
Sep 4, 2013·Arthritis Research & Therapy·Rina Mina, Hermine I Brunner
Jan 15, 2015·Pediatric Rheumatology Online Journal·Direkrit ChiewchengcholMichael W Beresford

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Lancet
Nathalie Costedoat-ChalumeauJean-Charles Piette
The New England Journal of Medicine
E DislaA Taranta
Acta reumatológica portuguesa
S A StudartW P Vieira
JAMA : the Journal of the American Medical Association
R K Winkelmann
© 2021 Meta ULC. All rights reserved